权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Methods for Enhancing Polygenic Risk Prediction Models for Complex Disease

增强复杂疾病多基因风险预测模型的方法

基本信息

批准号：
10717244
负责人：
Dokyoon Kim
金额：
$ 80.48万
依托单位：
UNIVERSITY OF PENNSYLVANIA
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-07-01 至 2027-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10717244
关键词：
Address Adopted African ancestry Area Atrial Fibrillation Cardiomyopathies Cardiovascular Diseases Cardiovascular system Clinical Complex Coronary Arteriosclerosis DNA Data Development Disease Early Diagnosis Early identification Electronic Health Record Electronic Medical Records and Genomics Network Emerging Technologies European ancestry Genetic Genetic Predisposition to Disease Genetic Risk Genome Goals Health Personnel Heart failure Incidence Individual Informatics Investigation Life Machine Learning Mathematics Medicine Methods Modeling Morbidity - disease rate Phenotype Precision Health Prevention Prevention strategy Preventive therapy Public Health Research Risk Risk Factors Scoring Method Surveys Testing Translating Translations Variant Vascular Diseases Veterans biobank cardiac muscle disease cardiovascular disorder risk cardiovascular risk factor clinical care clinical decision support clinical implementation clinical risk cohort data integration deep learning model design disorder prevention disorder risk early screening effective therapy exome genetic information genetic risk factor genetic variant genome-wide heart rhythm high risk population improved innovation machine learning method mortality non-genetic novel polygenic risk score predictive modeling pressure programs prototype rare variant response risk prediction risk prediction model social social health determinants statistics trait translational impact translational potential whole genome

项目摘要

PROJECT SUMMARY Early screening and prevention of individuals at risk of complex diseases are important strategies for reducing morbidity and mortality. Polygenic risk scores (PRS) are the cumulative, mathematical aggregation of risk derived from the contributions of many DNA variants across the genome. PRS are an emerging technology in the field of disease risk prediction and have been shown to be correlated with disease incidence. While PRS have shown great promise for complex diseases, current PRS models are overly simplistic and have limited predictive power and clinical utility. PRS do not account for the effects of rare genetic variants or other risk factors (clinical, environmental, social determinants of health) on disease risk. Rare variants generally have greater effects on disease risk due to selective pressure, but only a small number of individuals carry any single rare variant. The sparsity of rare variants makes it difficult to directly incorporate them into PRS. Additionally, while it is known that clinical, environmental, and social risk factors also influence risk, few analyses have successfully integrated PRS with these important non-genetic factors. To address this issue, we will develop novel translational informatics methods that integrate clinical, environmental, and genetic data to improve disease risk prediction. We will assess the clinical utility of these integrated risk prediction models using cardiovascular disease (CVD) to evaluate the potential for translation to clinical use. Based on the complexity of CVD, we hypothesize that a comprehensive range of risk factors along with rare variants need to be incorporated into PRS to improve the risk prediction and maximize the clinical utility of PRS for CVD. To achieve our goal, our specific aims are: 1) To develop novel methods that incorporate rare genetic variants into Polygenic Risk Scores (PRS); 2) To evaluate Integrated Risk Models that combine clinical, environmental, and social risk factors with PRS; 3) To develop and evaluate deep learning models integrating genetic, clinical, environmental, and social risk factors; 4) To translate our integrated models into the electronic health record (EHR). If these specific aims are achieved, we will have a set of integrated models that can be used in downstream clinical implementation programs to ultimately have a translational impact on disease treatment and prevention. Using these novel computational risk prediction models for precision health, along with our EHR integration approaches, will allow for the translation of integrated risk prediction into routine clinical care.

项目总结